David J. Calkins, PhD, Director of Research and Associate Professor, Department of Ophthalmology
Vanderbilt Eye Institute discusses the Catalyst For a Cure (CFC): A New Model for Scientific Research.
The Calkins lab focuses on the mechanisms of neurodegeneration in glaucoma. Using systems, cellular and molecular approaches, they investigate how risk factors contribute to neurodegeneration and test new treatments. Dr. Calkins specializes in molecular mechanisms of the retina and optic nerve.
In this video: Benefits of Collaborative Research; The Focus of CFC Research; A Neurobiological Approach to Glaucoma Research.
Link to this comment:
All Comments (0)